Search results for " events"

showing 10 items of 472 documents

The Relationship Between Work-Related Behavior and Experience Patterns and Organizational Commitment

2017

The challenges of today’s working life lead to stressful experiences and therefore to different types of coping patterns. The relationship between these coping patterns and organizational and professional commitment is not yet fully researched. This study has been conducted with about 180 participants using the questionnaires Work-related Behavior and Experience Patterns (AVEM—AVEM is the acronym for “Arbeitsorientiertes Verhaltens—und Erlebensmuster”which translates to Work-related Behavior and Experience Patterns) and the Test of Affective, Normative and Continuous Commitment to the Organization, the Profession and the Type of Employment. The results showed a significant correlation betwe…

Organizational citizenship behaviorCoping (psychology)030504 nursingbusiness.industryAffective events theoryOrganizational commitment030210 environmental & occupational healthWork related03 medical and health sciences0302 clinical medicineOrganizational learningNormative0305 other medical sciencebusinessPsychologyOrganizational behavior and human resourcesSocial psychology
researchProduct

Evapotranspiration simulations in ISIMIP2a-Evaluation of spatio-temporal characteristics with a comprehensive ensemble of independent datasets

2018

Actual land evapotranspiration (ET) is a key component of the global hydrological cycle and anessential variable determining the evolution of hydrological extreme events under different climate change scenarios. However, recently available ET products show persistent uncertainties thatare impeding a precise attribution of human-induced climate change. Here, we aim at comparing arange of independent global monthly land ET estimates with historical model simulations from theglobal water, agriculture, and biomes sectors participating in the second phase of the Inter-SectoralImpact Model Intercomparison Project (ISIMIP2a). Among the independent estimates, we use theEartH2Observe Tier-1 dataset …

PARAMETERIZATION010504 meteorology & atmospheric sciences0208 environmental biotechnologyREANALYSIS DATA02 engineering and technologyForcing (mathematics)01 natural sciencesISIMIP2aEnvironmental Science(all)Evapotranspirationddc:550Range (statistics)Cluster AnalysisMeteorology & Atmospheric SciencesWATERWater cycleuncertaintyGeneral Environmental ScienceUncertaintyVariance (accounting)Explained variationGLOBAL TERRESTRIAL EVAPOTRANSPIRATIONVariable (computer science)[SDU.STU.CL]Sciences of the Universe [physics]/Earth Sciences/ClimatologyClimatologyPhysical SciencesLife Sciences & BiomedicinePROJECTHYDROLOGICAL MODELSevapotranspirationClimate changeEnvironmental Sciences & EcologySOIL-MOISTUREhydrological extreme eventsLAND-SURFACE MODELhydrological extreme events ; cluster analysis ; uncertainty ; ISIMIP2a ; evapotranspiration[SDU.STU.HY]Sciences of the Universe [physics]/Earth Sciences/HydrologyHydrological extreme events0105 earth and related environmental sciencesScience & TechnologyRenewable Energy Sustainability and the EnvironmentPublic Health Environmental and Occupational HealthPOTENTIAL EVAPOTRANSPIRATION020801 environmental engineeringEarth sciencesISIMIP2a; evapotranspiration; uncertainty; cluster analysis; hydrological extreme events13. Climate actionEnvironmental scienceEnvironmental SciencesHIGH-RESOLUTIONcluster analysis
researchProduct

French Endocrine Society Guidance on endocrine side effects of immunotherapy.

2018

The management of cancer patients has changed due to the considerably more frequent use of immune checkpoint inhibitors (ICPIs). However, the use of ICPI has a risk of side effects, particularly endocrine toxicity. Since the indications for ICPI are constantly expanding due to their efficacy, it is important that endocrinologists and oncologists know how to look for this type of toxicity and how to treat it when it arises. In view of this, the French Endocrine Society initiated the formulation of a consensus document on ICPI-related endocrine toxicity. In this paper, we will introduce data on the general pathophysiology of endocrine toxicity, and we will then outline expert opinion focusing…

PD-L1Cancer Researchmedicine.medical_specialtyHypophysitisEndocrinology Diabetes and Metabolismmedicine.medical_treatmentImmune checkpoint inhibitorsimmune checkpoint inhibitorEndocrine System DiseasesGuidelines and GuidanceEndocrinologyAntineoplastic Agents ImmunologicalPD-1medicineAdrenal insufficiencyEndocrine systemHumansIn patientthyrotoxicosisIntensive care medicinediabetesbusiness.industryCommon Terminology Criteria for Adverse EventsImmunotherapymedicine.diseaseFrequent usehypophysitisOncologyCTLA-4FranceImmunotherapyhypothyroidismbusinessadrenal insufficiencyEndocrine-related cancer
researchProduct

Apparent Life-Threatening Events

2018

Objectives Apparent life-threatening event (ALTE) refers to a constellation of unexpected events suddenly occurring in infants that extremely alarm the observers. The objectives of this study were to evaluate 1) intervention of Emergency Service (ES) at home, 2) parental behavior before ES intervention, 3) patients' outcome at follow-up of a minimum of 6 months. Methods Retrospective study of infants younger than 12 months whose parents called ES and were evaluated for ALTE from 2005 to 2014. Tactile stimulation (TS) was defined as any maneuver performed by parents or ES staff aimed at rescuing patients without cardiopulmonary resuscitation attempts. Cardiopulmonary resuscitation was define…

ParentsMaleEmergency Medical ServicesPediatricsmedicine.medical_specialtymedicine.medical_treatmentFollow-Up Studie03 medical and health sciences0302 clinical medicine030225 pediatricsIntervention (counseling)Outcome Assessment Health CaremedicineEmergency medical servicesHumansPatient locationCardiopulmonary resuscitationRetrospective StudiesEmergencieEmergency Medical Servicebusiness.industryInfant NewbornInfant030208 emergency & critical care medicineRetrospective cohort studyapparent life-threatening eventGeneral MedicineEmergency departmentPhysiological responsesParenttactile stimulationPediatrics Perinatology and Child HealthApparent life-threatening eventsEmergency MedicineFemaleEmergenciesbusinessFollow-Up StudiesHumanPediatric Emergency Care
researchProduct

Experimental study of the triple-gluon vertex

1991

Abstract In four-jet events from e+e− →Z0 →multihadrons one can separate the three principal contributions from the triple-gluon vertex, double gluon-bremsstrahlung and the secondary quark-antiquark production, using the shape of the two-dimensional angular distributions in the generalized Nachtmann-Reiter angle θ NR ∗ and the opening angle of the secondary jets. Thus one can identify directly the contribution from the triple-gluon vertex without comparison with a specific non-QCD model. Applying this new method to events taken with the DELPHI-detector we get for the ratio of the colour factor Nc to the fermionic Casimir operator C F : N c C F = 2.55 ± 0.55 ( stat. ) ± 0.4 ( fragm. + models…

Particle physicsCOLLISIONSNuclear and High Energy PhysicsE+E ANNIHILATION[PHYS.HEXP] Physics [physics]/High Energy Physics - Experiment [hep-ex]LUND MONTE-CARLOElectron–positron annihilationHigh Energy Physics::LatticeNON-ABELIAN NATURE01 natural sciencesJET FRAGMENTATIONDECAYSPHYSICSAngular distribution3-GLUON VERTEX0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]010306 general physicsQuantum chromodynamicsPhysics010308 nuclear & particles physicsLUND MONTE-CARLO; NON-ABELIAN NATURE; 4-JET EVENTS; JET FRAGMENTATION; E+E ANNIHILATION; 3-GLUON VERTEX; QCD; PHYSICS; COLLISIONS; DECAYSHigh Energy Physics::PhenomenologyCasimir elementQCDVertex (geometry)Gluon4-JET EVENTSFísica nuclearHigh Energy Physics::ExperimentParticle Physics - Experiment
researchProduct

Search for diphoton events with large missing transverse energy in 7 TeV proton-proton collisions with the ATLAS detector.

2011

A search for diphoton events with large missing transverse energy is presented. The data were collected with the ATLAS detector in proton-proton collisions at √s=7  TeV at the CERN Large Hadron Collider and correspond to an integrated luminosity of 3.1  pb−1. No excess of such events is observed above the standard model background prediction. In the context of a specific model with one universal extra dimension with compactification radius R and gravity-induced decays, values of 1/R<729  GeV are excluded at 95% C. L., providing the most sensitive limit on this model to date.

Particle physicsMISSING TRANSVERSE ENERGYCiências Naturais::Ciências FísicasAtlas detector:Ciências Físicas [Ciências Naturais]FIS/04 - Fisica Nucleare e SubnucleareGeneral Physics and AstronomyFOS: Physical sciencestransverse energy: missing-energy ; ATLAS ; universal extra dimension ; compactification ; CERN LHC Coll ; background ; p p: interaction ; final state: two-photon ; photon: Kaluza-Klein ; electroweak interaction: standard model: validity test ; experimental results ; 7000 GeV-cmsddc:500.201 natural sciences7. Clean energy530High Energy Physics - ExperimentNuclear physicsUniversal extra dimensionHigh Energy Physics - Experiment (hep-ex)0103 physical sciencesddc:550[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]diphoton; events; transverse energy;proton-proton collisions; Hadron;ddc:530High Energy PhysicsSpecific model010306 general physicsNuclear ExperimentGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)QCPhysicsLarge Hadron ColliderScience & TechnologyCompactification (physics)010308 nuclear & particles physicsAtlas (topology)Settore FIS/01 - Fisica SperimentaleFísicaFIS/01 - Fisica SperimentaleATLASTransverse planeCol·lisions (Física nuclear)Experimental High Energy PhysicsUniversal Extra DimensionsFísica nuclearHigh Energy Physics::ExperimentLHCParticle Physics - ExperimentPhysical review letters
researchProduct

Search for diphoton events with large missing transverse momentum in 7 TeV proton-proton collision data with the ATLAS detector

2012

A search for diphoton events with large missing transverse momentum has been performed using proton–proton collision data at √s = 7 TeV recorded with the ATLAS detector, corresponding to an integrated luminosity of 4.8 fb[superscript −1]. No excess of events was observed above the Standard Model prediction and model-dependent 95% confidence level exclusion limits are set. In the context of a generalised model of gauge-mediated supersymmetry breaking with a bino-like lightest neutralino of mass above 50 GeV, gluinos (squarks) below 1.07 TeV (0.87 TeV) are excluded, while a breaking scale Λ below 196 TeV is excluded for a minimal model of gauge-mediated supersymmetry breaking. For a specific …

ParticleLambda01 natural sciencesHigh Energy Physics - ExperimentUniversal extra dimensionHigh Energy Physics - Experiment (hep-ex)proton-proton collisionExtensionBibliography[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]QCPhysicsLarge Hadron ColliderSettore FIS/01 - Fisica SperimentaleSupersymmetry breakingDynamical Supersymmetry BreakingComputingMethodologies_DOCUMENTANDTEXTPROCESSINGdiphoton events; ATLAS detectorUniversal Extra DimensionsPhenomenologyFísica nuclearPhenomenology (particle physics)Particle Physics - ExperimentParticle physicsNuclear and High Energy PhysicsFortran CodeCiências Naturais::Ciências FísicasAstrophysics::High Energy Astrophysical PhenomenaSupergauge Transformations:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesddc:500.2530Partícules (Física nuclear)Nuclear physicsMinimal model0103 physical sciencesddc:530010306 general physicsCiencias ExactasScience & TechnologyATLAS detector010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyFísicadiphotonHadron CollidersGeneratorsHADRON-HADRON COLLISIONSNeutralinoExperimental High Energy PhysicsHigh Energy Physics::ExperimentModel
researchProduct

Risk assessment in ginecology and obstetrics in Sicily: an approach based on Wolff's Criteria

2013

Objectives To apply Wolff’s Criteria to hospital discharge records (HDR) in order to detect adverse events worthy of further study. Methods Gynecology and Obstetrics Units of three Sicilian hospitals were considered and HDR regarding ordinary and day hospital admissions in 2008 were collected. A matched case-control study was designed, by random selection of 10 controls at maximum for each case. Matching was performed on the variables age and speciality of admission (gynecology or obstetrics). Results Out of a total of 7011 HDR examined, 114 cases were identified with Wolff’s Criteria. Multivariate analysis confirmed a statistically significant association with the origin of admission, diag…

Patient TransferReoperationGenital Neoplasms FemaleSettore MED/42 - Igiene Generale E ApplicataPatient ReadmissionRisk AssessmentSettore MED/01 - Statistica MedicaGynecologic Surgical ProceduresPregnancyRisk FactorsAmbulatory CarePrevalenceHumansHospital MortalityObstetrics and Gynecology Department HospitalRisk ManagementLength of StayDelivery ObstetricQuality ImprovementPatient DischargeIntensive Care UnitsItalyCase-Control StudiesWolff’s Criteria Adverse Events Clinical Risk Obstetrics GynecologyFemalePatient SafetyEmergencies
researchProduct

Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions.

2014

In Italy, the introduction of Universal Varicella Vaccination (UVV) has been decided but postponed, as a national programme, until 2015, when data from Regions which have already implemented it will be available. Starting from 2003, eight Italian Regions (Basilicata, Calabria, Friuli Venezia Giulia, Apulia, Sardinia, Sicily, Tuscany and Veneto) have progressively introduced UVV, in their immunization programme, with different schedules in children aged 13-15 months and 5-6 years, currently a two-dose schedule is adopted by all Regions. In June 2013, an Interregional Group on Varicella Vaccination (IGVV) has been established in order to assess the effectiveness of varicella vaccination with …

Pediatricsmedicine.medical_specialtyImmunologyadverse events following varicella immunizationVaricellaSettore MED/42 - Igiene Generale E ApplicataEnvironmental healthmedicineImmunology and AllergyHealth policyChickenpox VaccinePharmacologyChickenpoxbusiness.industryIncidence (epidemiology)immunization coverageHealth services researchUniversal Varicella VaccinationnotificationsVaricella; Universal Varicella Vaccination; Notifications; Hospitalizations; Immunization coverage; Adverse effectsmedicine.diseaseVaccinationImmunizationVaccination coverageUniversal Varicella Vaccination; Varicella; adverse events following varicella immunization; hospitalizations; immunization coverage; notificationsbusinesshospitalization
researchProduct

Data of safety in a single-center alemtuzumab treated population

2020

Alemtuzumab is approved for highly active MS and, in Europe, can be employed after other disease-modifying treatments (DMTs) as an escalation approach or first therapeutic option. The occurrence of secondary autoimmune adverse events and infections differs depending on the employed approach.In the manuscript entitled “Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: report from a single Italian center” by di Ioia M. and collaborators, efficacy and safety data of alemtuzumab were evaluated in a real-world MS population. The aim of the article is to describe in detail the unexpected serious adverse events which occurred in this cohort during and after the administr…

Pediatricsmedicine.medical_specialtyPopulationlcsh:Computer applications to medicine. Medical informaticsSingle CenterMultiple sclerosis03 medical and health sciences0302 clinical medicinemedicinelcsh:Science (General)Adverse effecteducationAutoimmune hemolytic anemiaAlemtuzumabSecondary autoimmune disorders030304 developmental biology0303 health scienceseducation.field_of_studyMultidisciplinarybusiness.industryMultiple sclerosismedicine.diseasePancytopeniaAdverse eventsCohortlcsh:R858-859.7AlemtuzumabSettore MED/26 - NeurologiaAutoimmune hemolytic anemiaSafetybusiness030217 neurology & neurosurgerylcsh:Q1-390medicine.drugNeuroscience
researchProduct